Evidence map›Paper›PMID 30214395›Full record

ArticleFrontiers in molecular neuroscience2018

Deciphering the Contributions of CRH Receptors in the Brain and Pituitary to Stress-Induced Inhibition of the Reproductive Axis.

Androniki Raftogianni, Lena C Roth, Diego García-González, Thorsten Bus, Claudia Kühne, Hannah Monyer, Daniel J Spergel, Jan M Deussing, Valery Grinevich

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Regulation of theFrontiers in endocrinology · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. The reproductive stress hypothesis.Reproduction (Cambridge, England) · 2019
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Androniki RaftogianniSchaller Group on Neuropeptides, German Cancer Research Center, Heidelberg - Central Institute of Mental Health, Mannheim, Germany.
Lena C RothDepartment of Molecular Neurobiology, Max Planck Institute for Medical Research, Heidelberg, Germany.
Diego García-GonzálezDepartment of Clinical Neurobiology, Medical Faculty of Heidelberg, University of Heidelberg - German Cancer Research Center, Heidelberg, Germany.
Thorsten BusDepartment of Molecular Neurobiology, Max Planck Institute for Medical Research, Heidelberg, Germany.
Claudia KühneMolecular Neurogenetics Research Group, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
Hannah MonyerDepartment of Clinical Neurobiology, Medical Faculty of Heidelberg, University of Heidelberg - German Cancer Research Center, Heidelberg, Germany.
Daniel J SpergelDepartment of Neurosurgery, Yale University School of Medicine, New Haven, CT, United States.
Jan M DeussingMolecular Neurogenetics Research Group, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
Valery GrinevichSchaller Group on Neuropeptides, German Cancer Research Center, Heidelberg - Central Institute of Mental Health, Mannheim, Germany.
Max Planck Institute for Medical Research · DEMax Planck Institute of Psychiatry · DECentral Institute of Mental Health · DEGerman Cancer Research Center · DEHeidelberg University · DEUniversity Hospital Heidelberg · DEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on pharmacological studies, corticotropin-releasing hormone (CRH) and its receptors play a leading role in the inhibition of the hypothalamic-pituitary-gonadal (HPG) axis during acute stress. To further study the effects of CRH receptor signaling on the HPG axis, we generated and/or employed male mice lacking CRH receptor type 1 (CRHR1) or type 2 (CRHR2) in gonadotropin-releasing hormone neurons, GABAergic neurons, or in all central neurons and glia. The deletion of CRHRs revealed a preserved decrease of plasma luteinizing hormone (LH) in response to either psychophysical or immunological stress. However, under basal conditions, central infusion of CRH into mice lacking CRHR1 in all central neurons and glia, or application of CRH to pituitary cultures from mice lacking CRHR2, failed to suppress LH release, unlike in controls. Our results, taken together with those of the earlier pharmacological studies, suggest that inhibition of the male HPG axis during acute stress is mediated by other factors along with CRH, and that CRH suppresses the HPG axis at the central and pituitary levels via CRHR1 and CRHR2, respectively.

Indexed as

CRHCRH receptorsGnRHGnRH neuronsgonadotropesreproductionstress

Identifiers

PMID30214395
PMCPMC6125327
OpenAlexW2889210073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.